Li Xiang
Chongqing, 400038, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Corrigendum to "KIAA1429 facilitates metastasis via m6A-YTHDC1-dependent RND3 down-regulation in hepatocellular carcinoma cells" [Canc. Lett. 584 (2024) 216598].
Journal: Cancer letters
Published: March 05, 2025
"TFEB-HNRNPA2B1": A positive feedback loop facilitating metastasis in hepatocellular carcinoma cells.
Journal: Experimental cell research
Published: February 17, 2025
Deacetylation of ANXA2 by SIRT2 desensitizes hepatocellular carcinoma cells to donafenib via promoting protective autophagy.
Journal: Cell death and differentiation
Published: July 14, 2024
Lopinavir enhances anoikis by remodeling autophagy in a circRNA-dependent manner.
Journal: Autophagy
Published: March 04, 2024
Contrast‑associated acute kidney injury in myocardial infarction patients undergoing elective percutaneous coronary intervention: insight from the Iodixanol-AKI Registry.
Journal: Internal and emergency medicine
Published: March 01, 2024
Inhibition of KIAA1429/HK1 axis enhances the sensitivity of liver cancer cells to sorafenib by regulating the Warburg effect.
Journal: Biochemical pharmacology
Published: February 14, 2024
CircPHKB decreases the sensitivity of liver cancer cells to sorafenib via miR-1234-3p/CYP2W1 axis.
Journal: Genomics
Published: June 26, 2023
Iodixanol-associated acute kidney injury and prognosis in patients undergoing elective percutaneous coronary intervention: a prospective, multi-center study.
Journal: European radiology
Published: April 15, 2023
Dihydroergotamine mesylate enhances the anti-tumor effect of sorafenib in liver cancer cells.
Journal: Biochemical pharmacology
Published: December 07, 2022
Dichloroacetate enhances the anti-tumor effect of sorafenib via modulating the ROS-JNK-Mcl-1 pathway in liver cancer cells.
Journal: Experimental cell research
Published: January 29, 2021
Showing 1-11 of 11
Last Updated: 09/26/2026